Biogen’s Experimental Alzheimer’s Drug Shows ‘Favorable Trends’

  • 📰 BNNBloomberg
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 50%

Entertainment Entertainment Headlines News

Entertainment Entertainment Latest News,Entertainment Entertainment Headlines

Biogen Inc. said it saw “favorable trends” in patients taking its experimental Alzheimer’s disease therapy that targets a buildup of a protein called tau in the brain, in a release of early data Wednesday.

Bitcoin Has More Than Doubled This Year In Unforeseen ResurgenceBillionaire Oil Clan Gets $900 Million Dividend From UK BusinessAI Backlash May Bring Social Unrest to UK, Infosys Boss SaysSouth African Unions Free Some Miners Held UndergroundInvestors Tell Scotland a Bond Would Raise Profile, Incur CostsUS New-Home Sales Surge to Fastest Clip Since February 2022Restaurant Owners Are Fed Up With Reservation-Hoarding BotsT-Mobile Raises Guidance as Profit, Subscribers Beat EstimatesIsrael Latest:...

Here's what experts think is nextBank of Canada rate pause will help cool rental market: experts'Soft landing' with poor GDP growth not a good outcome: Frances DonaldGrocers called back to Parliament to testify about plans to stabilize pricesThe Daily Chase: Teck, GM report earnings; Microsoft, Alphabet coming laterMacklem warned premiers about dangers of putting BoC's independence at riskAutoworkers strike at Stellantis plant shutting down big profit center, 41,000 workers now...

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 83. in ENTERTAİNMENT

Entertainment Entertainment Latest News, Entertainment Entertainment Headlines